Charitos Ioannis Alexandros, Topi Skender, Castellaneta Francesca, D'Agostino Donato
Department of Emergency/Urgency, National Poisoning Center, Riuniti University Hospital (OO.RR.) of Foggia, 71122 Foggia, Italy.
School of Technical Medical Sciences, University A. Xhuvani, Elbasan 3001, Albania.
Antibiotics (Basel). 2019 May 7;8(2):56. doi: 10.3390/antibiotics8020056.
In the area of Emergency Room (ER), many patients present criteria compatible with a SIRS, but only some of them have an associated infection. The new definition of sepsis by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine (2016), revolutionizes precedent criteria, overcoming the concept of SIRS and clearly distinguishing the infection with the patient's physiological response from the symptoms of sepsis. Another fundamental change concerns the recognition method: The use of SOFA (Sequential-Sepsis Related-Organ Failure Assessment Score) as reference score for organ damage assessment. Also, the use of the qSOFA is based on the use of three objective parameters: Altered level of consciousness (GCS <15 or AVPU), systolic blood pressure ≤ 100 mmHg, and respiratory rate ≥ 22/min. If patients have at least two of these altered parameters in association with an infection, then there is the suspicion of sepsis. In these patients the risk of death is higher, and it is necessary to implement the appropriate management protocols, indeed the hospital mortality rate of these patients exceeds 40%. Patients with septic shock can be identified by the association of the clinical symptoms of sepsis with persistent hypotension, which requires vasopressors to maintain a MAP of 65 mmHg, and serum lactate levels >18 mg/dL in despite of an adequate volume resuscitation. Then, patient first management is mainly based on: (1) Recognition of the potentially septic patient (sepsis protocol-qSOFA); (2) Laboratory investigations; (3) Empirical antibiotic therapy in patients with sepsis and septic shock. With this in mind, the authors discuss the most important aspects of the sepsis in both adults and infants, and also consider the possible treatment according current guidelines. In addition, the possible role of some nutraceuticals as supportive therapy in septic patient is also discussed.
在急诊室(ER)区域,许多患者表现出与全身炎症反应综合征(SIRS)相符的标准,但其中只有一部分患者伴有感染。欧洲重症监护医学学会和危重病医学会(2016年)对脓毒症的新定义彻底改变了先前的标准,克服了SIRS的概念,并明确区分了感染与患者的生理反应以及脓毒症的症状。另一个根本性变化涉及识别方法:使用序贯器官衰竭评估(SOFA)评分作为评估器官损伤的参考评分。此外,快速序贯器官衰竭评估(qSOFA)的使用基于三个客观参数:意识水平改变(格拉斯哥昏迷量表评分<15或使用AVPU评估)、收缩压≤100 mmHg和呼吸频率≥22次/分钟。如果患者至少有两个这些改变的参数且伴有感染,则怀疑有脓毒症。在这些患者中,死亡风险更高,因此有必要实施适当的管理方案,实际上这些患者的医院死亡率超过40%。脓毒性休克患者可通过脓毒症的临床症状与持续性低血压相关联来识别,并需要使用血管升压药来维持平均动脉压(MAP)为65 mmHg,且尽管进行了充分的液体复苏,血清乳酸水平仍>18 mg/dL。然后,患者的首要管理主要基于:(1)识别潜在的脓毒症患者(脓毒症方案-qSOFA);(2)实验室检查;(3)对脓毒症和脓毒性休克患者进行经验性抗生素治疗。考虑到这一点,作者讨论了成人和婴儿脓毒症的最重要方面,并根据当前指南考虑了可能的治疗方法。此外,还讨论了一些营养保健品作为脓毒症患者支持性治疗的可能作用。